← Leaderboards
Lawrence Kwong
University Of Tx Md Anderson Can Ctr
$3,868,475
Attributed
$5,210,832
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2020–24$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,210,832 · 2
By mechanism
R01$5,210,832 · 2
Top collaborators
- Omid Veiseh3 shared
- David Yu Zhang1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Michael Davies$11,575,720
- Michael W Andreeff$17,991,896
- Ruy Lopez Ridaura$1,748,418
- Cassian Yee$17,221,393
- Laszlo George Radvanyi$2,629,361
Others in their field
Other Emerging Leaders on “Mutation”
- Leonard Freedman · Leidos Biomedical Research, Inc.$85,874,322
- John Damon Chodera · Sloan-Kettering Inst Can Research$48,421,310
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$38,744,543
- Lynn Briscoe · Leidos Biomedical Research, Inc.$38,032,945
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- James Dale Berry · Brigham And Women'S Hospital$19,118,191
Research focus
MutationBiological ModelsTargeted TreatmentSeriesDrug ResistancePre-ClinicalPharmaceutical PreparationsPatient-Focused OutcomesPreventSamplingToxic EffectTreatment EfficacyResistance MechanismResistanceGenesMelanomaMouse ModelInstitutionCell ModelCell LineBraf GeneCell GrowthCell Cycle ArrestBiopsy
Grant awards (9)
A Convergent Node in Melanoma to Block Multiple Oncogenic Pathways Simultaneously$489,697
R01 · FY2024 · CA · contact PI
Optimizing Detection and Interventions Against Rare Pre-existing Drug Resistance Mutations$664,591
R01 · FY2023 · HG · contact PI
A Convergent Node in Melanoma to Block Multiple Oncogenic Pathways Simultaneously$505,159
R01 · FY2023 · CA · contact PI
Optimizing Detection and Interventions Against Rare Pre-existing Drug Resistance Mutations$664,591
R01 · FY2022 · HG · contact PI
A Convergent Node in Melanoma to Block Multiple Oncogenic Pathways Simultaneously$495,751
R01 · FY2022 · CA · contact PI
Optimizing Detection and Interventions Against Rare Pre-existing Drug Resistance Mutations$664,591
R01 · FY2021 · HG · contact PI
A Convergent Node in Melanoma to Block Multiple Oncogenic Pathways Simultaneously$516,411
R01 · FY2021 · CA · contact PI
Optimizing Detection and Interventions Against Rare Pre-existing Drug Resistance Mutations$690,941
R01 · FY2020 · HG · contact PI
A Convergent Node in Melanoma to Block Multiple Oncogenic Pathways Simultaneously$519,100
R01 · FY2020 · CA · contact PI